Tumor necrosis factor receptor cross-talk

FEBS Journal

Volumn 278, Issue 6, 2011, Pages 888-898

  Naudé, Petrus J W ^a   Den Boer, Johan A ^a   Luiten, Paul G M ^a   Eisel, Ulrich L M ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

apoptosis; cross talk; inhibitor of apoptosis (IAP); NF kappa B; PI3K; protein kinase B Akt; RIP; TNF receptor associated factor (TRAF); TNFR1; TNFR2

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

APOPTOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CELLULAR IMMUNITY; ENZYME ACTIVATION; HUMAN; INTRACELLULAR SIGNALING; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; TRANSPORT KINETICS;

ANIMALS; CELL SURVIVAL; HUMANS; MICE; NF-KAPPA B; RECEPTOR CROSS-TALK; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 1; TNF RECEPTOR-ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952509253     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08017.x     Document Type: Review

References (84)

1. Grell M, (1995) Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF. J Inflamm 47, 8-17. (Pubitemid 26376197)
2. Wajant H, Pfizenmaier K, &, Scheurich P, (2003) Tumor necrosis factor signaling. Cell Death Differ 10, 45-65. (Pubitemid 36511832)
3. Hohmann HP, Remy R, Brockhaus M, &, van Loon AP, (1989) Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). J Biol Chem 264, 14927-14934. (Pubitemid 19237319)
4. Loetscher H, Pan Y-CE, Lahm H-W, Gentz R, Brockhaus M, Tabuchi H, &, Lesslauer W, (1990) Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61, 351-359.
5. Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GHW, Gatanaga T, Granger GA, Lentz R, Raab H, (1990) Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61, 361-370. (Pubitemid 120035001)
6. Smith C, Davis T, Anderson D, Solam L, Beckmann M, Jerzy R, Dower S, Cosman D, &, Goodwin R, (1990) A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248 (4958), 1019-1023.
7. Fiers W, (1991) Tumor necrosis factor characterization at the molecular, cellular and in vivo level. FEBS Lett 285, 199-212.
8. Tartaglia LA, &, Goeddel DV, (1992) Two TNF receptors. Immunol Today 13, 151-153.
9. Choi SJ, Lee K-H, Park HS, Kim S-K, Koh C-M, &, Park JY, (2005) Differential expression, shedding, cytokine regulation and function of TNFR1 and TNFR2 in human fetal astrocytes. Yonsei Med J 46, 818-826. (Pubitemid 43085186)
10. Faustman D, &, Davis M, (2010) TNF receptor 2 pathway: drug target for autoimmune diseases. Nat Rev Drug Discov 9, 482-493.
11. Gaur U, &, Aggarwal BB, (2003) Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 66, 1403-1408. (Pubitemid 38373326)
12. Aggarwal BB, (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3, 745-756. (Pubitemid 41070815)
13. MacEwan DJ, (2002) TNF receptor subtype signalling: differences and cellular consequences. Cell Signal 14, 477-492. (Pubitemid 34230583)
14. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schrelber R, Mak TW, &, Bloom BR, (1995) Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2, 561-572.
15. Deckert-Schluter M, Bluethmann H, Rang A, Hof H, &, Schluter D, (1998) Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis. J Immunol 160, 3427-3436. (Pubitemid 28164736)
16. Loetscher H, Stueber D, Banner D, Mackay F, &, Lesslauer W, (1993) Human tumor necrosis factor alpha (TNF alpha) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors. J Biol Chem 268, 26350-26357. (Pubitemid 23361709)
17. van der Poll T, Jansen PM, Van Zee KJ, Welborn MB III, de Jong I, Hack CE, Loetscher H, Lesslauer W, Lowry SF, &, Moldawer LL, (1996) Tumor necrosis factor-alpha induces activation of coagulation and fibrinolysis in baboons through an exclusive effect on the p55 receptor. Blood 88, 922-927. (Pubitemid 26333315)
18. Kim EY, Priatel JJ, Teh S-J, &, Teh H-S, (2006) TNF receptor type 2 (p75) functions as a costimulator for antigen-driven T cell responses in vivo. J Immunol 176, 1026-1035. (Pubitemid 43099703)
19. Kafrouni MI, Brown GR, &, Thiele DL, (2003) The role of TNF-TNFR2 interactions in generation of CTL responses and clearance of hepatic adenovirus infection. J Leukoc Biol 74, 564-571. (Pubitemid 38040384)
20. Liu J, Zhao MQ, Xu L, Ramana CV, Declercq W, Vandenabeele P, &, Enelow RI, (2005) Requirement for tumor necrosis factor-receptor 2 in alveolar chemokine expression depends upon the form of the ligand. Am J Respir Cell Mol Biol 33, 463-469. (Pubitemid 41572689)
21. Ban L, Zhang J, Wang L, Kuhtreiber W, Burger D, &, Faustman DL, (2008) Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism. Proc Natl Acad Sci USA 105, 13644-13649.
22. Van Herreweghe F, Festjens N, Declercq W, &, Vandenabeele P, (2010) Tumor necrosis factor-mediated cell death: to break or to burst, that's the question. Cell Mol Life Sci 67, 1567-1579.
23. Fontaine V, Mohand-Said S, Hanoteau N, Fuchs C, Pfizenmaier K, &, Eisel U, (2002) Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci 22, 1-7.
24. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, &, Ting JPY, (2001) TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4, 1116-1122. (Pubitemid 34116557)
25. Welborn MB III, Van Zee K, Edwards PD, Pruitt JH, Kaibara A, Vauthey JN, Rogy M, Castleman WL, Lowry SF, Kenney JS, (1996) A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon. J Exp Med 184, 165-171. (Pubitemid 26247226)
26. The Lenercept Multiple Sclerosis Study Group & The University of British Columbia MS/MRI Analysis Group (1999) TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 53, 457-465.
27. van Oosten BW, Barkhof F, Truyen L, Boringa JB, Bertelsmann FW, von Blomberg BM, Woody JN, Hartung HP, &, Polman CH, (1996) Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47, 1531-1534. (Pubitemid 26422549)
28. Hamid T, Gu Y, Ortines RV, Bhattacharya C, Wang G, Xuan Y-T, &, Prabhu SD, (2009) Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation. Circulation 119, 1386-1397.
29. Grell M, Douni E, Wajant H, Löhden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K, (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83, 793-802.
30. Tuma R, Russell M, Rosendahl M, &, Thomas GJ, (1995) Solution conformation of the extracellular domain of the human tumor necrosis factor receptor probed by Raman and UV-resonance Raman spectroscopy: structural effects of an engineered PEG linker. Biochemistry 34, 15150-15156.
31. Chan FK-M, Chun HJ, Zheng L, Siegel RM, Bui KL, &, Lenardo MJ, (2000) A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288 (5475), 2351-2354. (Pubitemid 30448156)
32. Tartaglia LA, Ayres TM, Wong GHW, &, Goeddel DV, (1993) A novel domain within the 55 kd TNF receptor signals cell death. Cell 74, 845-853. (Pubitemid 23270604)
33. Jiang Y, Woronicz JD, Liu W, &, Goeddel DV, (1999) Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science 283 (5401), 543-546.
34. Boldin MP, Goncharov TM, Goltseve YV, &, Wallach D, (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor induced cell death. Cell 85, 803-815.
35. Hsu H, Huang J, Shu H-B, Baichwal V, &, Goeddel DV, (1996) TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387-396. (Pubitemid 26174054)
36. Ting AT, Pimentel-Muinos FX, &, Seed B, (1996) RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J 15, 6189-6196. (Pubitemid 26397891)
37. Chen N-J, Chio IIC, Lin W-J, Duncan G, Chau H, Katz D, Huang H-L, Pike KA, Hao Z, Su Y-W, (2008) Beyond tumor necrosis factor receptor: TRADD signaling in toll-like receptors. Proc Natl Acad Sci USA 105, 12429-12434.
38. Micheau O, &, Tschopp J, (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181-190. (Pubitemid 36936912)
39. Lee TH, Shank J, Cusson N, &, Kelliher MA, (2004) The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2. J Biol Chem 279, 33185-33191. (Pubitemid 39062963)
40. Mahoney DJ, Cheung HH, Mrad RL, Plenchette S, Simard C, Enwere E, Arora V, Mak TW, Lacasse EC, Waring J, (2008) Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc Natl Acad Sci USA 105, 11778-11783.
41. Varfolomeev E, Goncharov T, Fedorova AV, Dynek JN, Zobel K, Deshayes K, Fairbrother WJ, &, Vucic D, (2008) c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. J Biol Chem 283, 24295-24299.
42. Wajant H, &, Scheurich P, (2011) TNFR1-induced activation of the classical NF-κB pathway. FEBS J doi: 10.1111/j.1742-4658.2011.08015.x.
43. Ea C-K, Deng L, Xia Z-P, Pineda G, &, Chen ZJ, (2006) Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 22, 245-257.
44. Wu C-J, Conze DB, Li T, Srinivasula SM, &, Ashwell JD, (2006) Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation. Nat Cell Biol 8, 398-406.
45. Blonska M, Shambharkar PB, Kobayashi M, Zhang D, Sakurai H, Su B, &, Lin X, (2005) TAK1 is recruited to the tumor necrosis factor-α (TNF-α) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-κB activation. J Biol Chem 280, 43056-43063. (Pubitemid 43049271)
46. Israel A, (2006) NF-kappaB activation: nondegradative ubiquitination implicates NEMO. Trends Immunol 27, 395-397. (Pubitemid 44216191)
47. Wang C-Y, Mayo MW, Korneluk RG, Goeddel DV, &, Baldwin AS Jr, (1998) NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 1680-1683.
48. Schneider-Brachert W, Tchikov V, Neumeyer J, Jakob M, Winoto-Morbach S, Held-Feindt J, Heinrich M, Merkel O, Ehrenschwender M, Adam D, (2004) Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 21, 415-428. (Pubitemid 39208342)
49. Yeh WC, Pompa JL, McCurrach ME, Shu HB, Elia AJ, Shahinian A, Ng M, Wakeham A, Khoo W, Mitchell K, El-Deiry WS, (1998) FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279, 1954-1958. (Pubitemid 28168653)
50. O'Donnell MA, &, Ting AT, (2011) RIP1 comes back to life as a cell death regulator in TNFR1signaling. FEBS J doi: 10.1111/j.1742-4658.2011.08016.x.
51. Liu Z-G, Hsu H, Goeddel DV, &, Karin M, (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87, 565-576. (Pubitemid 26374329)
52. Muppidi JR, Tschopp J, &, Siegel RM, (2004) Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction. Immunity 21, 461-465. (Pubitemid 39370502)
53. Rothe M, Pan M-G, Henzel WJ, Ayres TM, &, Goeddel DV, (1995) The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83, 1243-1252. (Pubitemid 26007814)
54. Thommesen L, &, Laegreid A, (2005) Distinct differences between TNF receptor 1- and TNF receptor 2-mediated activation of NFkappaB. J Biochem Mol Biol 38, 281-289. (Pubitemid 43034367)
55. Rauert H, Wicovsky A, Müller N, Siegmund D, Spindler V, Waschke J, Kneitz C, &, Wajant H, (2010) Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2). J Biol Chem 285, 7394-7404.
56. Marchetti L, Klein M, Schlett K, Pfizenmaier K, &, Eisel ULM, (2004) Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-d-aspartate receptor activation: essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-κB pathway. J Biol Chem 279, 32869-32881. (Pubitemid 39014747)
57. Rothe M, Wong SC, Henzel WJ, &, Goeddel DV, (1994) A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681-692. (Pubitemid 24268590)
58. Rothe M, Sarma V, Dixit VM, &, Goeddel DV, (1995) TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269 5229, 1424-1427.
59. Sun S-C, &, Ley SC, (2008) New insights into NF-kappaB regulation and function. Trends Immunol 29, 469-478.
60. Al-Lamki RS, Wang J, Vandenabeele P, Bradley JA, Thiru S, Luo D, Min W, Pober JS, &, Bradley JR, (2005) TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury. FASEB J 19, 1637-1645. (Pubitemid 41429521)
61. Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, Li Q, Guzman JR, Korgaonkar CK, &, Donner DB, (2004) Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappaB activation. J Biol Chem 279, 1615-1620. (Pubitemid 38084426)
62. Eisel ULM, Biber K, &, Luiten PGM, (2006) Life and death of nerve cells: therapeutic cytokine signaling pathways. Curr Signal Transduct Ther 1, 133-146.
63. Bigda J, Beletsky I, Brakebusch C, Varfolomeev Y, Engelmann H, Holtmann H, &, Wallach D, (1994) Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J Exp Med 180, 445-460. (Pubitemid 24224121)
64. Medvedev AE, Sundan A, &, Espevik T, (1994) Involvement of the tumor necrosis factor receptor p75 in mediating cytotoxicity and gene regulating activities. Eur J Immunol 24, 2842-2849. (Pubitemid 24342205)
65. Wajant H, Henkler F, &, Scheurich P, (2001) The TNF-receptor- associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal 13, 389-400. (Pubitemid 32510989)
66. Fotin-Mleczek M, Henkler F, Samel D, Reichwein M, Hausser A, Parmryd I, Scheurich P, Schmid JA, &, Wajant H, (2002) Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. J Cell Sci 115, 2757-2770. (Pubitemid 34846516)
67. Roy N, Deveraux QL, Takahashi R, Salvesen GS, &, Reed JC, (1997) The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 16, 6914-6925. (Pubitemid 27520792)
68. Chan FK-M, &, Lenardo MJ, (2000) A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes. Eur J Immunol 30, 652-660. (Pubitemid 30098860)
69. Li X, Yang Y, &, Ashwell JD, (2002) TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416 6878, 345-347.
70. Wu CJ, Conze DB, Li X, Ying SX, Hanover JA, &, Ashwell JD, (2005) TNF-alpha induced c-IAP1/TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitination. EMBO J 24, 1886-1898. (Pubitemid 40769507)
71. Wicovsky A, Henkler F, Salzmann S, Scheurich P, Kneitz C, &, Wajant H, (2009) Tumor necrosis factor receptor-associated factor-1 enhances proinflammatory TNF receptor-2 signaling and modifies TNFR1-TNFR2 cooperation. Oncogene 28, 1769-1781.
72. Schwenzer R, Siemienski K, Liptay S, Schubert G, Peters N, Scheurich P, Schmid RM, &, Wajant H, (1999) The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-κB and c-Jun N-terminal kinase. J Biol Chem 274, 19368-19374.
73. Carpentier I, &, Beyaert R, (1999) TRAF1 is a TNF inducible regulator of NF-kappaB activation. FEBS Lett 460, 246-250. (Pubitemid 29495949)
74. Tsitsikov EN, Laouini D, Dunn IF, Sannikova TY, Davidson L, Alt FW, &, Geha RS, (2001) TRAF1 is a negative regulator of TNF signaling: enhanced TNF signaling in TRAF1-deficient mice. Immunity 15, 647-657. (Pubitemid 33016449)
75. Arron JR, Pewzner-Jung Y, Walsh MC, Kobayashi T, &, Choi Y, (2002) Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling. J Exp Med 196, 923-934.
76. Speiser DE, Lee SY, Wong B, Arron J, Santana A, Kong Y-Y, Ohashi PS, &, Choi Y, (1997) A regulatory role for TRAF1 in antigen-induced apoptosis of T cells. J Exp Med 185, 1777-1783. (Pubitemid 27242199)
77. Bradley JR, &, Pober JS, (2001) Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20, 6482.
78. Kalb A, Bluethmann H, Moore MW, &, Lesslauer W, (1996) Tumor necrosis factor receptors (Tnfr) in mouse fibroblasts deficient in Tnfr1 or Tnfr2 are signaling competent and activate the mitogen-activated protein kinase pathway with differential kinetics. J Biol Chem 271, 28097-280104.
79. Nishitoh H, Saitoh M, Mochida Y, Takeda K, Nakano H, Rothe M, Miyazono K, &, Ichijo H, (1998) ASK1 is essential for JNK/SAPK activation by TRAF2. Mol Cell 2, 389-395. (Pubitemid 128379279)
80. Zhao Y, Conze DB, Hanover JA, &, Ashwell JD, (2007) Tumor necrosis factor receptor 2 signaling induces selective c-IAP1-dependent ASK1 ubiquitination and terminates mitogen-activated protein kinase signaling. J Biol Chem 282, 7777-7782. (Pubitemid 47093598)
81. Yamada K, Iida R, Miyamoto Y, Saito K, Sekikawa K, Seishima M, &, Nabeshima T, (2000) Neurobehavioral alterations in mice with a targeted deletion of the tumor necrosis factor-alpha gene: implications for emotional behavior. J Neuroimmunol 111, 131-138.
82. Bradham CA, Plumpe J, Manns MP, Brenner DA, &, Trautwein C, (1998) Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am J Physiol Gastrointest Liver Physiol 275, G387-G392.
83. Willuweit A, Sass G, Schoneberg A, Eisel U, Tiegs G, &, Clauss M, (2001) Chronic inflammation and protection from acute hepatitis in transgenic mice expressing TNF in endothelial cells. J Immunol 167, 3944-3952. (Pubitemid 32910840)
84. Baune BT, Wiede F, Braun A, Golledge J, Arolt V, &, Koerner H, (2008) Cognitive dysfunction in mice deficient for TNF-α and its receptors. Am J Med Genet 147B, 1056-1064.